prednisolone 4 MG/ML Oral Solution

What the CMS Formulary Data Shows for prednisolone 4 MG/ML Oral Solution

Per the CMS 2026 Part D formulary file, prednisolone 4 MG/ML Oral Solution (RxNorm concept RXCUI 702306, generic name prednisolone) appears on 45 distinct formulary files spanning 1,791 Medicare Part D plan offerings - 35.3% of enrollable Part D products, selective placement; verify formulary inclusion before enrolling. Tier placement ranges from Tier 1 to Tier 4, with a cross-plan average of Tier 2.5.

Real-world access to prednisolone 4 MG/ML Oral Solution depends on utilization management as much as tier placement: 22.2% of covering formularies require prior authorization. 0% require step therapy. 0% apply quantity limits.

Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 20,337 Part D beneficiaries filled prednisolone 4 MG/ML Oral Solution in 2023, with total plan-and-beneficiary spending of $1,319,595 and an average per-beneficiary annual cost of $64.89. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry prednisolone 4 MG/ML Oral Solution today.